2019 International Congress

Monday, September 23, 2019

1:45pm-3:15pm

Distinct phenotypic expression in a large PKAN cohort in the Dominican Republic

S. Baser, C. Muniz, F. Middleton, R. Ericson, M. Santana Jimenez, C. Bass (Pittsburgh, PA, USA)

Rare Genetic and Metabolic Diseases  ·  Les Muses Terrace, Level 3

1:45pm-3:15pm

Distribution Characteristics of Limbs Discomfort in Restless Legs Syndrome

X. Li, YC. Wu, XY. Zhu (Shanghai, China)

Restless Leg Syndrome, RBD and Other Sleep Disorders  ·  Les Muses Terrace, Level 3

1:45pm-3:15pm

Does cognitive-motor training improve the balance in Parkinson’s disease? Randomized clinical trial

M. Terra, N. Barboza, I. de Almeida, M. Bueno, S. Smaili (Londrina, Brazil)

Physical and Occupational Therapy  ·  Les Muses Terrace, Level 3

1:45pm-3:15pm

Does Gait in Real Life differ between People with Parkinson’s Disease and Healthy Controls?

V. Shah, J. Mcnames, C. Curtze, M. Mancini, P. Carlson-Kuhta, J. Nutt, M. El Gohary, F. Horak (Portland, OR, USA)

Clinical Trials, Pharmacology and Treatment  ·  Agora 3 West, Level 3

1:45pm-3:15pm

Does information from the Personal KinetiGraph™ (PKG) influence neurologists´ treatment decisions?

M. Sundgren, P. Rousu, A. Johansson (Stockholm, Sweden)

Other  ·  Agora 2 West, Level 2

1:45pm-3:15pm

Does REM Sleep Behavior Disorder Change in the Progression of Parkinson’s Disease?

M. Figorilli, A. Marques, M. Meloni, B. Pereira, M. Puligheddu, F. Durif, ML. Fantini (Clermont-Ferrand, France)

Restless Leg Syndrome, RBD and Other Sleep Disorders  ·  Les Muses Terrace, Level 3

1:45pm-3:15pm

Does socio-economic status have impact on quality of life in persons with Parkinson’s disease?

R. Aggarwal, V. Goyal, A. Srivastava, M. Behari (Delhi, India)

Quality of Life  ·  Les Muses Terrace, Level 3

1:45pm-3:15pm

Does Team-based Outpatient Palliative Care Improve Patient or Care Partner-Centered Outcomes in Parkinson’s Disease and Related Disorders?

B. Kluger, M. Katz, N. Galifianakis, K. Hall, S. Pantilat, R. Khan, C. Friedman, W. Cernik, J. Long, J. Kutner, S. Sillau, J. Miyasaki (San Francisco, CA, USA)

Clinical Trials, Pharmacology and Treatment  ·  Agora 3 West, Level 3

1:45pm-3:15pm

Dopamine agonist withdrawal syndrome in Sardinian patients affected by Parkinson’s disease

P. Paolo, R. Pau, G. Orofino, T. Ercoli, F. Marrosu, G. Defazio (Monserrato, Italy)

Psychiatric Manifestations  ·  Les Muses Terrace, Level 3

1:45pm-3:15pm

Dopamine receptor variants alter outcomes with levodopa in early-stage Parkinson’s disease

D. Fischer, P. Auinger, J. Goudreau, A. Cole-Strauss, K. Kieburtz, J. Elm, M. Hacker, P. Charles, J. Lipton, B. Pickut, C. Sortwell (Grand Rapids, MI, USA)

Clinical Trials, Pharmacology and Treatment  ·  Agora 3 West, Level 3